The phrase "abnormal outcome" is correct and usable in written English.
It can be used in contexts such as medical reports, research findings, or any situation where results deviate from the expected norm.
Example: "The study revealed an abnormal outcome that necessitated further investigation into the underlying causes."
Alternatives: "unusual result" or "atypical finding".
Patients who had a (history of) an endocrine abnormality, an abnormal outcome of blood biochemistry or hematology, an abnormal cervical smear, a chronic disease, relevant ovarian-, tubal- or uterine-pathology that could interfere with the COS treatment (e.g. endometrioma >0 mm or fibroids ≥5 cm), embryo implantation or pregnancy were not to be included in the trial.
Measuring the success of US energy diplomacy is difficult, and failure is not an abnormal outcome.
To study the relationships between 2D ultrasound measurements of placentation and maternal serum (MS) levels of PAPP-A, inhibin A and fβhCG in early pregnancy and subsequent fetal growth in pregnancies with a normal and abnormal outcome.
These deletions and duplications are thought to be contributory, but not always sufficient, to elicit an abnormal outcome.
However, in this instance, the opposite effect is seen with FBP reconstruction leading to an abnormal outcome while other reconstructions give a normal outcome.
Moderate HIE occurred in 18 infants, of whom 10/18 (55.6%) had abnormal outcome.
Furthermore, our analysis does not have the power to detect abnormal outcomes that occur at relatively low background rates or rare abnormalities, and the issues of long-term social or functional development cannot be monitored.
We believe that is not always the case and that one should not base intent on statistical analyses, which can be helpful in showing an adviser was aware that his returns were higher than his clients' but can also identify abnormal outcomes in an environment free from wrongdoing.
Patients with clinically detectable ketonuria were at increased risk relative to patients without ketonuria for abnormal outcomes during postterm testing, including the presence of oligohydramnios (24% vs 9.3%; P <.0001 ), nonreactive nonstress tests (6.2% vs 2.15%; P <.0001), and fetal heart rate decelerations (14% vs 9.2%; P =.0039 ).
Other than 13 spontaneous abortions (4 in participants receiving SAVVY and 9 in participants receiving placebo), no abnormal outcomes were reported.
Nevertheless due to low number of cases with severely-abnormal outcomes, we have decided to add all recordings delivered by Cesarean Section (CS) with abnormal outcomes that conformed with the requirements mentioned above (16 CS records).
